Skip to Content

Tag: Spirosure

Also Noted

CAIRE acquires respiratory device maker

June 5, 2020HME News Staff

BALL GROUND, Ga. - CAIRE has acquired Spirosure, a California-based company that recently launched its first product to market, the Fenom Pro, a device that measures FeNO, a key indicator of allergic inflammation in asthmatic patients. “FeNo is quickly becoming recognized by the clinical community as an important diagnostic and management tool for clinicians who treat asthma patients,” said Earl Lawson, CAIRE president and CEO. “The acquisition of Spirosure further diversifies our...

Asthma, CAIRE, Spirosure

Read Full Articlered right arrow icon